| scholarly article | Q13442814 |
| P2093 | author name string | A P Rice | |
| F Carlotti | |||
| P2860 | cites work | Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein | Q24656004 |
| Structural and functional characterization of human immunodeficiency virus tat protein | Q24656163 | ||
| Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins | Q27861094 | ||
| RNA-binding proteins as developmental regulators | Q28237577 | ||
| A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins | Q28246228 | ||
| Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product | Q29615049 | ||
| HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
| A tripartite HIV-1 tat-env-rev fusion protein | Q33918908 | ||
| Structural and functional characterization of the short acidic transcriptional activation region of yeast GCN4 protein | Q34172416 | ||
| HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. | Q34186306 | ||
| Cooperative activation of a eukaryotic transcription factor: interaction between Cu(I) and yeast ACE1 protein | Q34289491 | ||
| Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
| Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events | Q34344850 | ||
| Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat | Q34563887 | ||
| The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
| Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. | Q34564460 | ||
| Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis | Q35226113 | ||
| 5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis | Q35943171 | ||
| Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein | Q36804564 | ||
| Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
| trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. | Q36832567 | ||
| Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro | Q37398372 | ||
| Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
| Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat | Q38346354 | ||
| Regulatory pathways governing HIV-1 replication | Q38360638 | ||
| Mutational effects on protein stability | Q38686707 | ||
| HIV TAR: an RNA enhancer? | Q38708348 | ||
| Genetic studies of protein stability and mechanisms of folding | Q39653536 | ||
| Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat | Q40129795 | ||
| A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator | Q40650101 | ||
| Transcriptional but not translational regulation of HIV-1 by the tat gene product. | Q44298589 | ||
| Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity | Q44335635 | ||
| HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
| Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes | Q45831871 | ||
| Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
| Tat protein from human immunodeficiency virus forms a metal-linked dimer | Q45841752 | ||
| Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
| Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat | Q46674379 | ||
| HIV-1 TAT "activates" presynthesized RNA in the nucleus | Q48291503 | ||
| Genes-in-pieces revisited. | Q53728552 | ||
| Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1 | Q68126223 | ||
| Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev | Q68505951 | ||
| The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain | Q69366191 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6018-6026 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins | |
| P478 | volume | 64 |
| Q34593969 | A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects |
| Q35870516 | Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. |
| Q54225233 | Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter. |
| Q34888756 | Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA. |
| Q40676905 | Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein. |
| Q24548355 | FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles |
| Q40047125 | Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. |
| Q36326743 | Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort |
| Q39619066 | Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia |
| Q24543241 | HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. |
| Q33815080 | Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate |
| Q38317787 | Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells |
| Q33930741 | Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators |
| Q24676286 | Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor |
| Q39877972 | RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. |
| Q33192810 | Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat) |
| Q40273841 | Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein |
| Q35059684 | Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription |
| Q36642378 | TAR RNA binding properties and relative transactivation activities of human immunodeficiency virus type 1 and 2 Tat proteins. |
| Q33957746 | Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase |
| Q24682531 | The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function |
| Q29614788 | Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro |
| Q39272683 | Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA. |
Search more.